The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis.

Pflüger MJ, Griffin JF, Hackeng WM, Kawamoto S, Yu J, Chianchiano P, Shin E, Lionheart G, Tsai HL, Wang H, Rezaee N, Burkhart RA, Cameron JL, Thompson ED, Wolfgang CL, He J, Brosens LAA, Wood LD

Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy.

Maeda S, Mederos MA, Chawla A, Moore AM, Shoucair S, Yin L, Burkhart RA, Cameron JL, Park JY, Girgis MD, Wainberg ZA, Hines OJ, Fernandez-Del Castillo C, Qadan M, Lillemoe KD, Ferrone CR, He J, Wolfgang CL, Burns WR, Yu J, Donahue TR

Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?

Blair AB, Beckman RM, Habib JR, Griffin JF, Lafaro K, Burkhart RA, Burns W, Weiss MJ, Cameron JL, Wolfgang CL, He J

Incidence and Contemporary Management of Delayed Bleeding Following Pancreaticoduodenectomy.

Habib JR, Gao S, Young AJ, Ghabi E, Ejaz A, Burns W, Burkhart R, Weiss M, Wolfgang CL, Cameron JL, Liddell R, Georgiades C, Hong K, He J, Lafaro KJ

Mexico: the Inaugural International Chapter of the Society for Surgery of the Alimentary Tract.

Montalvo-Jave EE, Ayala-Moreno EA, Soper NJ, Ashley SW, Stain S, Pawlik TM, Pellegrini C, Cameron JL, Vauthey JN, Jones D, Sarr MG, Callery MP, Chaba SS

Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.

Javed AA, Ding D, Baig E, Wright MJ, Teinor JA, Mansoor D, Thompson E, Hruban RH, Narang A, Burns WR 3rd, Burkhart RA, Lafaro K, Weiss MJ, Cameron JL, Wolfgang CL, He J

Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.

Gemenetzis G, Blair AB, Nagai M, Groot VP, Ding D, Javed AA, Burkhart RA, Fishman EK, Hruban RH, Weiss MJ, Cameron JL, Narang A, Laheru D, Lafaro K, Herman JM, Zheng L, Burns WR 3rd, Wolfgang CL, He J

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ

Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.

Bertsimas D, Margonis GA, Huang Y, Andreatos N, Wiberg H, Ma Y, Mcintyre C, Pulvirenti A, Wagner D, van Dam JL, Gavazzi F, Buettner S, Imai K, Stasinos G, He J, Kamphues C, Beyer K, Seeliger H, Weiss MJ, Kreis M, Cameron JL, Wei AC, Kornprat P, Baba H, Koerkamp BG, Zerbi A, D'Angelica M, Wolfgang CL

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.

Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassiy C